Meloxivet Inyectable
Meloxicam exerts potent, selective inhibitory activity on Cyclooxygenase-2 (COX-2), both in vivo and in vitro, within the prostaglandin biosynthetic cascade. This selective and specific COX-2 blockade has demonstrated anti-inflammatory, analgesic, anti-exudative, and antipyretic properties, with minimal gastrolesive or ulcerogenic effects.
TARGET SPECIES
DOSAGE FORM
HOW SUPPLIED
DIFFERENTIATORS
BENEFITS AND COMPETITIVE ADVANTAGES
Rapid onset of action
Useful when oral administration is not possible.
Rapid onset of action
TECHNICAL DETAILS
Information
COMPOSITION
– Excipients q.s. to 1 ml.
DOSAGE AND ADMINISTRATION
Dogs: 0.2 mg/kg on the first day, then 0.1 mg/kg on subsequent days.
Cats: to prevent postsurgical pain and inflammation, an initial premedication dose of 0.3 mg/kg may be given, followed 24 hours later by 0.1 mg total. Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
- Joint Health
- Opioid Pain Management
- NSAID Pain Management
- Neuropathic Pain
- Steroidal Anti-inflammatory Drugs
- Antibiotics
- Gastrointestinal Health
- Hepatic Health
- Integrative Functional Supplementation
- Vitamins and Minerals
- Omega
- Laxatives
- Anticholinergic – Antispasmodics
- Hemostatic Agents
- Internal Antiparasitics
- External Antiparasitics
- Hemostatic Agent
Meloxivet Inyectable
TARGET SPECIES
DOSAGE FORM
HOW SUPPLIED
Meloxicam exerts potent, selective inhibitory activity on Cyclooxygenase-2 (COX-2), both in vivo and in vitro, within the prostaglandin biosynthetic cascade. This selective and specific COX-2 blockade has demonstrated anti-inflammatory, analgesic, anti-exudative, and antipyretic properties, with minimal gastrolesive or ulcerogenic effects.
Rapid onset of action
Useful when oral administration is not possible.
Rapid onset of action
TECHNICAL DETAILS
Information
COMPOSITION
– Excipients q.s. to 1 ml.
DOSAGE AND ADMINISTRATION
Dogs: 0.2 mg/kg on the first day, then 0.1 mg/kg on subsequent days.
Cats: to prevent postsurgical pain and inflammation, an initial premedication dose of 0.3 mg/kg may be given, followed 24 hours later by 0.1 mg total. Dosage and treatment duration may be adjusted based on the clinical picture, at the discretion of the attending veterinary professional.
